Cargando…

New way, new recommendation: Individualized treatment of novel antidiabetic drugs for people living with type 2 diabetes based on the cardiorenal risks

Detalles Bibliográficos
Autores principales:	Xu, Xiang, Bi, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298198/ https://www.ncbi.nlm.nih.gov/pubmed/34724335 http://dx.doi.org/10.1111/jebm.12452

Ejemplares similares

The way COVID-19 transforms our sexual lives
por: Nessaibia, Issam, et al.
Publicado: (2021)

DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases
por: Handelsman, Yehuda, et al.
Publicado: (2022)

Editorial: New Advances in Cardiorenal Syndrome
por: Calvier, Laurent, et al.
Publicado: (2022)

C-Type Natriuretic Peptide in Essential Hypertension: Old Ways for a New Time
por: Perunovic, Tara, et al.
Publicado: (2023)

Distinguishing Allies from Enemies—A Way for a New Green Revolution
por: Lino-Neto, Teresa, et al.
Publicado: (2022)

Integrated Interventions to Bridge Medical and Social Care for People Living with Diabetes
por: Gunter, Kathryn E., et al.
Publicado: (2023)

The Current Status of New Antidiabetic Drugs
por: Pemminati, Sudhakar, et al.
Publicado: (2016)

Pharmacogenetics of new classes of antidiabetic drugs
por: Kadrić, Selma Imamović, et al.
Publicado: (2021)

The residual cardiorenal risk in type 2 diabetes
por: Giugliano, Dario, et al.
Publicado: (2021)

Oxidative Stress Management in Cardiorenal Diseases: Focus on Novel Antidiabetic Agents, Finerenone, and Melatonin
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Finding a way to preserve mitochondria: new pathogenic pathways in experimental multiple sclerosis
por: Mancini, Andrea, et al.
Publicado: (2019)

Type 2 diabetes and metabolic surgery guidelines and recommendations should urgently be unified
por: Halpern, Bruno, et al.
Publicado: (2020)

The Diabetic Cardiorenal Nexus
por: D’Elia, John A., et al.
Publicado: (2022)

Geriatric assessment for older people with cancer: policy recommendations
por: Seghers, P. A. L., et al.
Publicado: (2023)

Cardiorenal Syndrome: New Pathways and Novel Biomarkers
por: Gembillo, Guido, et al.
Publicado: (2021)

New aspects in cardiorenal syndrome and HFpEF
por: Méndez, Ana Belén, et al.
Publicado: (2022)

COVID-19 and mental health: Building back better or reimagining a new way forward?
por: Tomlinson, Mark, et al.
Publicado: (2023)

Current gaps in management and timely referral of cardiorenal complications among people with type 2 diabetes mellitus in the Middle East and African countries: Expert recommendations
por: Sonmez, Alper, et al.
Publicado: (2022)

A new potential mode of cardiorenal protection of KLOTHO gene variability in type 1 diabetic adolescents
por: Słomiński, Bartosz, et al.
Publicado: (2020)

Recommendations for conducting longitudinal studies with people who are justice involved
por: Fradley, Marley F., et al.
Publicado: (2022)

Synthetic living machines: A new window on life
por: Ebrahimkhani, Mo R., et al.
Publicado: (2021)

The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivo
por: Gámez, Beatriz, et al.
Publicado: (2021)

Removing constraints to sustainable food production: new ways to exploit secondary metabolism from companion planting and GM
por: Pickett, John A, et al.
Publicado: (2019)

Paclitaxel: new uses for an old drug
por: Zhang, Dongshan, et al.
Publicado: (2014)

New insights into the pathophysiological mechanisms underlying cardiorenal syndrome
por: Wang, Jin, et al.
Publicado: (2020)

New Advances in Cardiorenal Syndrome—Ready for Prime Time?
por: Pliquett, Rainer U.
Publicado: (2022)

New Insight in Cardiorenal Syndrome: From Biomarkers to Therapy
por: Gallo, Giovanna, et al.
Publicado: (2023)

Personality network neuroscience: Promises and challenges on the way toward a unifying framework of individual variability
por: Hilger, Kirsten, et al.
Publicado: (2021)

Genetics provides new individualized therapeutic targets for Parkinson’s disease
por: Garcia, Eric Joshua, et al.
Publicado: (2020)

Digital Spindle: A New Way to Explore Mitotic Functions by Whole Cell Data Collection and a Computational Approach
por: Yamashita, Norio, et al.
Publicado: (2020)

Mechanisms of drugs in the treatment of type 2 diabetes mellitus
por: Yang, Tao, et al.
Publicado: (2023)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Lo, Chris Wai Hang, et al.
Publicado: (2021)

Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs
por: Signorovitch, J E, et al.
Publicado: (2013)

Talking about Sexuality in Stroke Individuals: The New Era of Sexual Rehabilitation
por: Contrada, Marianna, et al.
Publicado: (2023)

New roles for renin and prorenin in heart failure and cardiorenal crosstalk
por: Schroten, Nicolas F., et al.
Publicado: (2011)

A brand-new cardiorenal syndrome in the COVID-19 setting
por: Apetrii, Mugurel, et al.
Publicado: (2020)

Microalbuminuria and cardiorenal risk: old and new evidence in different populations
por: Márquez, Diego Francisco, et al.
Publicado: (2019)

Cardiorenal Protection in Diabetic Kidney Disease
por: Lee, Jason F., et al.
Publicado: (2021)

Cardiorenal syndrome and diabetes: an evil pairing
por: Méndez Fernández, Ana Belén, et al.
Publicado: (2023)

Reexploring 5-methoxyindole-2-carboxylic acid (MICA) as a potential antidiabetic agent
por: Yan, Liang-Jun
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_puo8ruand2faqtiel2uevbb6sf